cdp 840 has been researched along with rs 14203 in 1 studies
| Studies (cdp 840) | Trials (cdp 840) | Recent Studies (post-2010) (cdp 840) | Studies (rs 14203) | Trials (rs 14203) | Recent Studies (post-2010) (rs 14203) |
|---|---|---|---|---|---|
| 18 | 0 | 3 | 5 | 0 | 1 |
| Protein | Taxonomy | cdp 840 (IC50) | rs 14203 (IC50) |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 0.1167 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 0.005 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 0.005 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jabaris, SS; Kodimuthali, A; Pal, M | 1 |
1 review(s) available for cdp 840 and rs 14203
| Article | Year |
|---|---|
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2008 |